Biventricular pacemaker and defibrillator implantation in patients with chronic heart failure in China.

ABSTRACT:

Aims

This study aims to investigate the current status of biventricular pacemaker and defibrillator implantation in chronic heart failure (CHF) patients with indications for primary prevention of sudden cardiac death (SCD) in China and the effects of cardiac resynchronization therapy (CRT)-pacemaker (P) and CRT-defibrillator (D) implantation on the clinical prognosis of CHF among patients undergoing CRT.

Methods and results

Overall, 798 consecutive patients who had devices implanted (implantable cardioverter defibrillator: 199, CRT-D: 362, and CRT-P: 237) from May 2012 to July 2013 in POSCD-China, a multicentric prospective cohort study, were enrolled. The primary endpoint was all-cause death, and the secondary endpoint was SCD. In total, 71.3% of patients had non-ischaemic

SUBMITTER: Huang D 

PROVIDER: S-EPMC7835594 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature